(KKR)

The deal values the Swedish company at $1.2 billion, and the Biotage board recommended that shareholders accept the offer.

Sweden's Biotage said on Tuesday that KKR had made a cash offer for the Swedish biotechnology firm, valuing it at around 11.6 billion Swedish crowns ($1.22 billion).

NEW YORK--(BUSINESS WIRE)--KKR Real Estate Finance Trust Inc. (the “Company” or “KREF”) (NYSE: KREF) announced that the Board of Directors has declared a dividend of $0.40625 per each issued and outst...

NEW YORK--(BUSINESS WIRE)--KKR Real Estate Finance Trust Inc. (“KREF”) (NYSE: KREF) announced today that it has changed the time of its first quarter 2025 earnings conference call and webcast. The con...

FS KKR Capital's stock is undervalued, trading at a 21% discount to NAV, presenting a compelling buying opportunity despite higher-than-average non-accruals and declining net investment income. The BD...

The traditional 60-40 strategy has failed to deliver meaningful returns during recent market cycles. We discuss why the 60-40 strategy may be structurally broken going forward. We share an approach th...

FS KKR Capital offers a high dividend yield of 15%, with shares trading at an inexpensive valuation, making it an attractive entry point. Despite a 12% decline in net investment income per share, the ...

Private equity firm KKR is close to acquiring Frankfurt-listed IT services provider Datagroup , people familiar with the matter told Reuters on Tuesday.

CME Group and S&P Global have agreed to sell OSTTRA to investment funds managed by investment firm KKR for an enterprise value of $3.1 billion.